Posted on 10 June 2025 by Northern RNA
CALGARY, CANADA – 10 June 2025 – Northern RNA, a leading contract drug manufacturing organization (CDMO) specializing in GMP manufacturing of RNA-based vaccines and therapeutics, today announced that Todd Howren will be joining Northern RNA as Chief Commercial Officer (CCO).
“We are thrilled to welcome Todd Howren to our executive team,” said Brad Stevens, CEO of Northern RNA. “Todd’s proven leadership and deep industry expertise will be instrumental in driving our commercial strategy and expanding our global footprint.”
Todd Howren brings over 25 years of experience in the life sciences industry, including fifteen years of business development leadership experience.
Before joining Northern RNA, Todd served as the Senior Vice President of Sales and Marketing at Landmark Bio where he formally launched the company’s commercial business unit. At Aldevron he served as the Vice President of Sales and later as the head of Aldevron’s RNA Business Unit. As the Vice President of Global Commercial Operations at Meridian Bioscience, Todd led the Life Sciences Division’s Sales, Marketing, and Product Management. He also spent nearly 15 years at Thermo Fisher Scientific Corporation in various business development positions of increasing responsibility, ending as the lead for global strategy focusing on human molecular diagnostics and mRNA therapeutics. After graduate school, Todd began his career at Sigma-Aldrich, ending as National Sales Manager for Functional Genomics.
Todd earned his Bachelor of Science in Biology from Baylor University, Waco, Texas, and his Ph.D. in Physiology and Biophysics from the University of Arkansas for Medical Sciences, Little Rock, Arkansas. He has published several scientific papers and is an accomplished presenting expert at conferences and symposiums worldwide.
“The RNA landscape is transforming medicine, and Northern RNA is at the forefront of that change,” said Todd Howren, CCO. “I look forward to accelerating our commercial momentum, strengthening strategic partnerships, and delivering scalable solutions that meet the growing global demand.”
Contact Information
Northern RNA
Brad Stevens, CEO
About Northern RNA
Founded in 2020 to address unmet global demand for the manufacturing of vaccines and vaccine components, Northern RNA is a leading Contract Development and Manufacturing Organization (CDMO) specializing in the production of nucleic acid products used in applications including mRNA vaccines, DNA vaccines, mRNA therapies, gene editing, and gene therapies. Our goal is to provide secure, clinical-to-commercial scale, GMP-grade manufacturing for our customers across the globe. For more information about our end-to-end CDMO capabilities, please follow us on LinkedIn or visit us at www.northernrna.com.
#CDMO #RNA #mRNA #LNP #Lipids #oligo #Biomanufacturing #DrugDevelopment #CancerTherapy #Immunotherapy #Oncology #ManufacturingABetterFuture